HomeTopics › Snakebite Envenomation

Snakebite Envenomation

GMJ News knowledge hub · last reviewed August 2026 · Georgian Medical Journal

SummaryStatisticsGlossaryGMJ newsFAQDocumentsOrganizationsResearch

Snakebite envenomation kills an estimated 81,000 to 138,000 people every year — and causes permanent disability in up to 400,000 more through limb amputations, organ failure and neurological damage — making it one of the world's most lethal neglected tropical diseases, affecting primarily agricultural workers and children in rural South Asia, Sub-Saharan Africa and Latin America (WHO). Despite this enormous burden, antivenom — the only specific treatment — is unavailable, unaffordable or ineffective against local species in most endemic areas. WHO's Snakebite Envenomation Strategy targets a 50% reduction in snakebite deaths and disabilities by 2030.

Key messages

138,000 deaths per year
Snakebite envenomation kills an estimated 81,000 to 138,000 people per year — predominantly rural agricultural workers and children in South Asia and Sub-Saharan Africa — and leaves approximately 400,000 with permanent disability (WHO).
WHO NTD priority
Added to the WHO Neglected Tropical Diseases list in 2017, snakebite is now a formal global health priority — with WHO's Snakebite Envenomation Strategy targeting a 50% reduction in deaths and disabilities by 2030.
Antivenom access crisis
Antivenom — the only specific treatment for envenomation — is frequently unavailable, unaffordable, inappropriate for local snake species, or of poor quality in most endemic settings. The antivenom access gap is the central challenge of snakebite control.
5.4 million bites per year
Approximately 5.4 million people are bitten by snakes each year, of whom approximately 2.7 million are envenomed. Envenomation causes tissue necrosis, coagulopathy, neurotoxicity and organ failure depending on the snake species.
Agricultural workers and children
The highest-risk groups are agricultural workers (bitten while farming or harvesting), children (playing outdoors), and people sleeping on the ground. Snakebite is a disease of rural poverty — predominantly affecting people without healthcare access.
One Health approach
Snakebite prevention integrates animal (snake ecology), human behaviour (rubber boots, avoiding sleeping on ground, using a torch at night) and environmental (habitat management) strategies.

Key statistics

5.4M
snakebite incidents/year
WHO
81-138K
deaths/year
WHO
400K
permanent disabilities/year
WHO
2030
WHO target: 50% reduction in deaths
WHO
2017
year snakebite added to WHO NTD list
WHO
S. Asia
carries the highest burden — India has most deaths
WHO

Estimated snakebite deaths by region per year (thousands) — WHO

Source: WHO estimates. South Asia leads; Sub-Saharan Africa has second largest burden.

Glossary of key terms

Envenomation
WHO
The delivery of venom by a snakebite — causing clinical toxicity. Approximately 50% of bites are "dry bites" (no venom injected). Envenomation causes local tissue effects (necrosis, swelling) and/or systemic effects (coagulopathy, neurotoxicity, myotoxicity, nephrotoxicity).
Antivenom
WHO
The only specific treatment for snakebite envenomation — produced by immunising horses or sheep with snake venom, then extracting and purifying the antibodies. Must be matched to the local snake species. IV administration is required. High rates of anaphylaxis require adrenaline availability.
Viperidae (vipers)
WHO
Snakes of the family Viperidae — including Russell's viper, saw-scaled viper, puff adder, Gaboon viper. Cause predominantly local tissue effects (necrosis, blistering) and coagulopathy. The most clinically important family globally for human envenomation.
Elapidae (cobras, mambas, kraits)
WHO
Snakes of the family Elapidae — including cobras, mambas, kraits and sea snakes. Cause predominantly neurotoxicity (respiratory paralysis) and occasionally cytotoxic local effects. Responsible for many of the most lethal snakebites in Asia and Africa.
Necrosis from snakebite
WHO
Localised tissue destruction from viperid venom — causing permanent limb damage, requiring debridement, skin grafting or amputation. A major cause of the 400,000 permanent disabilities from snakebite annually.
Haemotoxicity
WHO/Clinical
Coagulopathy and haemorrhage from viperid venom interfering with blood clotting — causing venom-induced consumption coagulopathy (VICC), disseminated intravascular coagulation (DIC) and spontaneous bleeding. Treated with antivenom; fresh frozen plasma in coagulopathy.

Latest GMJ coverage

Articles will appear here as the archive grows.

Frequently asked questions 12 Q&A — structured for Google featured snippets and AI discovery

Knowledge hub: guidelines, conventions and reports

Organizations working in migration and health

Related health topics

NTDsOne HealthClimate (range expansion)Rural healthAMRChild health

About this hub. Produced by the GMJ News Editorial Team as a public-good service. Every statistic is linked to its primary source. Documents are preserved in the GMJ Repository with full attribution. Georgian Medical Journal · Contact the editorial team
GMJ BriefsView all →